Grants closing in July 2026

For mid-career researchers ready to lead a substantial research programme. Administering organisation must be in the UK, Republic of Ireland, or a low/middle-income country (excluding India and mainland China); must be a not-for-profit HEI, research institute, or healthcare organisation. Applicant must contribute at least 80% research time; health professionals must be registered with relevant regulator.

Open to researchers at Dutch institutions with an ongoing or recently finished KWF drug research project (start ≥6 months ago, end ≤1.5 years before 1 July 2026). Funds access to clinically relevant preclinical models, technologies and expertise (NAMs, PDOs, GEMMs, orthotopic models, CRO collaborations) to improve translational value. TRL ≥3 required; activities must relate to drug development/optimisation, not fundamental research alone.

Funds creation and development of Spanish research networks (Redes Temáticas, Redes ICTS, Redes Estratégicas, Redes para Planes Complementarios) to foster collaboration and synergies among research groups. Eligible applicants: universities, public R&D centres, technology centres, and non-profit entities linked to science/technology. Proposals must be submitted in Spanish. Part of Plan Estatal 2024-2027.

Royal Society Wolfson Fellowship from the Royal Society, the UK's national academy of sciences. Funds research and fellowships across the natural sciences; most schemes require a UK host institution (some exchange and visiting schemes involve overseas partners). Applications close 1 July 2026.

Royal Society Wolfson Visiting Fellowship from the Royal Society, the UK's national academy of sciences. Funds research and fellowships across the natural sciences; most schemes require a UK host institution (some exchange and visiting schemes involve overseas partners). Applications close 1 July 20

Open to consortia of Luxembourg-based private companies and public research institutions. Covers R&D in data analytics/HPC, AI (ML, computer vision, NLP, edge AI), and quantum technologies. Projects must be industrial research and/or experimental development. SMEs leading a project may receive 30% upfront payment. Self-funded international partners may participate. Proposals submitted via research-industry-collaboration.lu platform.

For senior researchers (PhD + 10 years minimum) affiliated to a Belgian university, university hospital, or eligible research institute until 31 Dec 2030. Funds rare disease research (bench to bedside); rare cancers and rare adverse drug events excluded. Proposals must be submitted in English. Up to 30% may be outsourced internationally or to the private sector.

Add-on funding exclusively for ongoing or recently completed KWF projects to strengthen translational relevance of oncology drug development. Supports training, implementation, and validation of advanced preclinical models; outsourcing to academic service providers or CROs is allowed.

13th call for translational oncology research projects. Applicants must read 'What to consider before applying' before submitting a LOI or project outline. Submissions accepted in German and/or English per guidelines.

Invites researchers and societal organisations to form a consortium to conduct research on reducing drug harm through effective societal interventions. Part of the NWA programme on drug harm reduction.

Bilateral Weave/Lead Agency call between SNSF and F.R.S.-FNRS (Belgium, Wallonia-Brussels). Swiss applicants apply under SNSF project funding; Belgian applicants must be based at one of six eligible universities (UCLouvain, ULB, ULiège, UMons, UNamur, USL-B). Max 2 simultaneous SNSF project grants allowed. Proposals in languages other than English (possible in some humanities/social sciences disciplines) require prior agreement with all agencies.

Funds academic-led clinical trials (Phase I–III) for new investigational medicinal products in oncology addressing unmet medical needs. Lead institute must be a medical centre or research institute in the Netherlands; public participating parties must be in Europe. Patient involvement is mandatory. Phase I/I-II budget: €1–2.5M; Phase II/III: €1–5M. Proposals must be in English. Public-private partnerships allowed; repurposing of registered drugs is out of scope.

Open to healthcare institutions, educational institutions, and non-profit organizations operating on Aruba, Bonaire, Curaçao, Sint Maarten, Statia, or Saba. Lead applicant must be based on one of the ABCSSS islands. At least 75% of budget must be spent locally on the islands. Proposals must be written in English. Co-financing encouraged but not mandatory.

Open to Dutch knowledge institutions, societal organisations and citizens. Consortium required (main applicant + co-applicant + cooperation partner). Phase 1 selects up to 4 pre-proposals; Phase 2 merges them into a single joint application via NWO-facilitated synergy workshops. Focuses on mechanisms of drug(-related) harm and effective societal interventions. Submissions via Mijn ZonMw only.

Thematic multilateral call under the ERDERA partnership (rare diseases). Budget cap per call and/or proposal applies. Luxembourg partner must submit INTER application at both pre-proposal and full proposal stage via FNR online system. Thematic call — no bottom-up funding.

T-AP P4T Call 2026 call from Poland's National Science Centre (NCN), funding basic research across all disciplines. Open to researchers at Polish host institutions; the international Weave-UNISONO and Trans-Atlantic Platform calls additionally involve foreign partner teams.

ERDERA call to solve undiagnosed rare genetic diseases and complex rare non-genetic diseases by identifying causative variants in patients with no prior molecular diagnosis. International joint call; Norwegian researchers must participate in a transnational consortium.

Share of £2M (inclusive of VAT) to develop innovative interventions, technologies, and frameworks supporting children and families experiencing homelessness. Open to organisations including those based in the EU, EEA, or internationally. Contracts awarded to a single legal entity only; subcontractors permitted but lead must be one organisation.

Joint transnational call under the ERDERA European rare disease research network. Requires international consortium across participating ERDERA member countries. Focus on rare/genetic diseases. Opened 10 December 2025.

Second funding phase of GroenvermogenNL WP2 focusing on liquid hydrogen import/transport/storage, hydrogen carrier conversion, and port infrastructure. NWO funds 51–80% of project costs; minimum 20% co-funding required from private parties or own contributions. Consortium must include organisations with demonstrable R&D activities in the Netherlands. Proposals must be submitted in English via ISAAC.

Continuation of 2024 PPE Consolidated Grants for two remaining years. Open to eligible UK research organisations that received a 2024 PPE award. Applicants must submit an update to their 2024 application; new or additional activities only in exceptional circumstances. STFC funds 80% FEC. Covers named experiments (ATLAS, CMS, LHCb, etc.) including M&O and common fund requests.

Supports internationally mobile postdoctoral researchers; international mobility is a key requirement (host lab must be in a different country). Includes salary/stipend, relocation allowance, and childcare support. A first-author refereed preprint is accepted as equivalent to a publication. Max one candidate per host lab per selection round.

Bilateral Flemish–French-speaking Belgium (FNRS) fundamental research project under the Weave Lead Agency Principle. Flemish supervisor-spokesperson must be eligible under FWO junior/senior project regulations (Article 7, 10–12). Proposals submitted in full to FNRS as Lead; Flemish side submits administrative form to FWO E-portal. Counts toward FWO's maximum of one active research project per applicant per round.

Bilateral Flemish–French-speaking Belgian collaborative fundamental research project under the Weave Lead Agency Principle. Flemish supervisor-spokesperson must be eligible under FWO junior/senior research project regulations. Flemish institutions must comply with FWO Article 7 conditions. Proposals submitted to FNRS as Lead Agency; FWO administrative submission via E-portal using form 'Research project WEAVE (FWO acts as Partner Agency)' within 7 days of FNRS deadline.

Long-term support for broad, multidisciplinary programmes with transformative potential in primary cancer prevention and population research.

Open to principal investigators at three career levels (Emerging, Ascending, Distinguished). Host institution must be in Denmark. Applicants must apply to the correct career-level category in the NORMA system; applications will not be transferred between categories. Covers data science research.

Open to UK research groups and individuals at any career stage (NERC eligibility applies). Must include at least one new international project partner (any country). NERC funds 80% FEC up to £100k; international partner travel/subsistence up to £15k at 100% FEC. Joint applications with São Paulo (FAPESP) or Taiwan (NSTC) partners eligible for co-funding. No PhD studentship costs or equipment ≥£25k. Projects must start by 1 February 2027.

Sandpit to co-develop projects enhancing existing ESRC social science data service infrastructures for federated discovery and access. Applicants must submit an individual expression of interest; in-person attendance at sandpit is mandatory. Institutions must fund 20% of full economic costs. International travel costs not covered. UK-based applicants at UKRI/ESRC-eligible organisations only.

Fondazione Umberto Veronesi post-doctoral fellowship in oncology (experimental / basic research track), funding cancer research in precision and translational medicine. Open to Italian and foreign researchers holding a PhD or medical specialisation, hosted at an Italian research institution. Early-c

Fondazione Umberto Veronesi post-doctoral fellowship in oncology (clinical research track), funding cancer research in precision and translational medicine. Open to Italian and foreign researchers holding a PhD or medical specialisation, hosted at an Italian research institution. Early-career age li

Funds long-term, integrated and potentially renewable programmes of exceptional science to drive transformational change in early cancer and pre-cancerous state detection and diagnosis.

For early-career researchers (PhD passed + ≤3 years postdoc, with allowances). Administering organisation must be in UK, Republic of Ireland, or eligible LMIC (not India or mainland China); must be not-for-profit HEI, research institute, or healthcare org. At least 80% research time required; no co-applicants accepted. Grant funds cannot be transferred to mainland China.

For early-career researchers (PhD passed + ≤3 years postdoc) at not-for-profit institutions in UK, Republic of Ireland, or eligible LMICs (excl. India and mainland China). Must contribute ≥80% research time. No co-applicants accepted. Funds salary plus up to £400k research expenses. Health professionals must hold relevant professional registration.

For early-career researchers across biomedical, clinical, social science, and arts & humanities disciplines. Applications managed in English on the Wellcome Funding platform; administering organisation must approve and submit by 15:00 GMT/BST on deadline day. Global eligibility; researchers based in LMICs encouraged. Global Talent visa endorsement available for UK-based award holders.

Invite-only call for UK university-led clusters bringing together academia, industry, and regional partners to drive R&D and growth in the creative industries. Proposals must address regional/national impact, include EDI framework, sustainability plan, and governance plan. Project partners (industry, academia, third sector, government, UK or overseas) are encouraged. No institutional matched funding requirement beyond standard 20% FEC.

Open to English Higher Education Providers registered with OfS (approved fee cap) and, under HERA 2017 s.97(3), organisations with strong KE/commercialisation metrics expertise. Applications can be collaborative or independent, but only eligible English HEPs or organisations may lead. Funds a national KE metrics advisory unit to design next-generation KE data tools, commercialisation metrics (spinouts, patents), and AI-based analytical approaches for policy and institutional funding.

Research opportunity focused on video games and gambling-related harms. Applicants must complete a Declaration of Interests Form disclosing any links to gambling operators or industry. Project partners from industry, academia, third sector or government (UK or overseas) are encouraged to contribute directly or in-kind.

Funding for the overarching coordination structure and leadership of the German Pancreatic Cancer Alliance (GPCA). Cancer research focus on pancreatic carcinoma. German-language call; applicants should be based at German institutions.

AGROECOLOGY Partnership R&I call covering Topic 1 (genetic diversity of crops/livestock for agroecological transition) and Topic 2 (farmer involvement and empowerment). International joint call requiring transnational consortia.

Supports researchers at the career development stage across a broad range of disciplines (biomedical, clinical, social sciences, arts & humanities, data sciences). Applications managed in English via the Wellcome Funding platform; host organisation must administer the grant. Global eligibility; UK-hosted awardees may access Global Talent visa endorsement.

For early-career independent investigators (lab established 3–8 years prior to Dec 31, 2026; i.e., 2018–2023). Open worldwide to non-profit academic/research institutions. Single PI only; no co-investigators. Applicants must have multi-year independent funding active in 2027. Proposals must be in English and distinct from the applicant's main research portfolio. Indirect costs capped at 10% of direct costs.

Supports exploratory, high-risk synthetic plant biology research applying engineering principles to plant function (e.g. sensors, stress tolerance, genetic modification). Applicants must hold a PhD and faculty/PI-equivalent position at a US nonprofit college, university, research institute, or eligible federal agency. No preliminary data required. No citizenship restrictions for PIs.

Curiosity-driven basic research in earth sciences, astronomy, chemistry, computer science, life sciences, physics or mathematics. Single main applicant with tenured or tenure-track position at eligible Dutch research organisation. Proposals must be in English. One submission per applicant per 12 months. ENW-M-1: single scientific position, max €400k.

International collaboration grant: Dutch main applicant (tenured/tenure-track at eligible NL institution) with co-applicant(s) from Germany/Luxembourg/Flanders. NWO acts as lead agency. Proposals in English. Covers a single temporary scientific position. Partner agencies: DFG, FNR, FWO.

MINIATURA 10 call from Poland's National Science Centre (NCN), funding basic research across all disciplines. Open to researchers at Polish host institutions; the international Weave-UNISONO and Trans-Atlantic Platform calls additionally involve foreign partner teams.

Dutch co-applicant submits administrative submission to NWO as partner agency for a Weave bilateral proposal led by DFG. Eligible applicants: full/associate/assistant professors or equivalent with tenured or tenure-track position at eligible Dutch institutions. Max one Dutch applicant; max €400k for one PhD or postdoc position plus other budget modules. Proposals must be in English. One ENW-M submission per 12 months rule applies.